SCHEMBL7472935

SCHEMBL7472935

CCCCCNc1nc(CC)c(-c2ccc(Cl)cc2C(F)(F)F)nc1OC

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7484320 0.90 CRHR1 (0.50) CRHR1
SCHEMBL5533539 0.89 CRHR1 (0.57) CRHR1
SCHEMBL7482439 0.85 CRHR1 (0.53) CRHR1
SCHEMBL7472159 0.84 CRHR1 (0.54) CRHR1
SCHEMBL7478694 0.82 CRHR1 (0.69) CRHR1
SCHEMBL5417311 0.82 CRHR1 (0.79) CRHR1
SCHEMBL7479379 0.80 CRHR1 (0.57) CRHR1
SCHEMBL7481208 0.78 CRHR1 (0.48) CRHR1
SCHEMBL6075200 0.78 CRHR1 (0.65) CRHR1
SCHEMBL7472124 0.77 CRHR1 (0.53) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed